Breast Cancer: ASCO 2025 TNBC & HER2-Low Updates Breast Cancer 4 Mins Read The ASCO 2025 breast cancer updates revealed exciting changes in treatment for triple-negative breast cancer (TNBC) and HER2-low cases. For…
Top 10 Breast Cancer Trials to Watch at ASCO 2025: OncologyTube Exclusive ASCO 3 Mins Read The American Society of Clinical Oncology (ASCO) Annual Meeting is a pivotal event for oncology professionals, and ASCO 2025, happening…
ASCENT Trial: Trodelvy Boosts Survival in Triple-Negative Breast Cancer Breast Cancer 4 Mins Read Overview of the ASCENT Trial and Trodelvy The ASCENT Trial (NCT02574455) is a Phase III study that compares Trodelvy (Sacituzumab…
